Organization
Horsham, PA
2 abstracts
Abstract
Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma.Org: Horsham, PA,
Abstract
Real-world treatment outcomes in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with first-line single-agent ibrutinib vs. chemoimmunotherapy.Org: Janssen Scientific Affairs, Titusville, NJ, Horsham, PA, PainReform,